Literature DB >> 19180485

Tissue targeting of anti-RNP autoimmunity: effects of T cells and myeloid dendritic cells in a murine model.

Eric L Greidinger1, Yunjuan Zang, Irina Fernandez, Mariana Berho, Mehdi Nassiri, Laisel Martinez, Robert W Hoffman.   

Abstract

OBJECTIVE: To explore the role of immune cells in anti-RNP autoimmunity in a murine model of pneumonitis or glomerulonephritis, using adoptive transfer techniques.
METHODS: Donor mice were immunized with 50 mug of U1-70-kd small nuclear RNP fusion protein and 50 mug of U1 RNA adjuvant. Whole splenocytes as well as CD4+ cell and dendritic cell (DC) subsets from the immunized mice were infused into naive syngeneic recipients. Anti-RNP and T cell responses were assessed by immunoblotting, enzyme-linked immunosorbent assay, and flow cytometry. Development of renal or lung disease was assessed by histology and urinalysis.
RESULTS: Unfractionated splenocytes from donor mice without proteinuria induced predominantly lung disease in recipients (8 [57%] of 14 versus 2 [14%] of 14 developing renal disease; P = 0.046). However, infusion of CD4+ cells from donors without proteinuria induced renal disease more frequently than lung disease (7 [70%] of 10 versus 2 [20%] of 10; P = 0.01); adoptive transfer of RNP+CD4+ T cells from short-term culture yielded similar results (renal disease in 8 [73%] of 11 recipients versus lung disease in 3 [27%] of 11). Cotransfer of splenic myeloid DCs and CD4+ T cells from immunized donors prevented induction of renal disease in all 5 recipients (P = 0.026 versus recipients of fresh CD4+ cells alone), although lung disease was still observed in 1 of 5 mice. Transfer of myeloid DCs alone from immunized donors induced lung disease in 3 (60%) of 5 recipients, without evidence of nephritis. Cotransfer of splenocytes from mice with and those without nephritis led to renal disease in 4 of 5 recipients, without evidence of lung disease.
CONCLUSION: These findings indicate that RNP+CD4+ T cells are sufficient to induce anti-RNP autoimmunity, tissue targeting in anti-RNP autoimmunity can be deviated to either a renal or pulmonary phenotype depending on the presence of accessory cells such as myeloid DCs, and DC subsets can play a role in both propagation of autoimmunity and end-organ targeting.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19180485      PMCID: PMC3059848          DOI: 10.1002/art.24256

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  28 in total

1.  Analysis of human T cell and B cell responses against U small nuclear ribonucleoprotein 70-kd, B, and D polypeptides among patients with systemic lupus erythematosus and mixed connective tissue disease.

Authors:  M M Holyst; D L Hill; S O Hoch; R W Hoffman
Journal:  Arthritis Rheum       Date:  1997-08

Review 2.  Type I interferon in systemic lupus erythematosus and other autoimmune diseases.

Authors:  Jacques Banchereau; Virginia Pascual
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

3.  Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.

Authors:  Sean R Christensen; Jonathan Shupe; Kevin Nickerson; Michael Kashgarian; Richard A Flavell; Mark J Shlomchik
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

4.  Different roles for human lung dendritic cell subsets in pulmonary immune defense mechanisms.

Authors:  Ingel K Demedts; Ken R Bracke; Tania Maes; Guy F Joos; Guy G Brusselle
Journal:  Am J Respir Cell Mol Biol       Date:  2006-04-20       Impact factor: 6.914

5.  Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD).

Authors:  E Bodolay; Z Szekanecz; K Dévényi; L Galuska; I Csípo; J Vègh; I Garai; G Szegedi
Journal:  Rheumatology (Oxford)       Date:  2005-02-16       Impact factor: 7.580

6.  Naming names! Comment on the article by Smolen and Steiner.

Authors:  D Isenberg; C Black
Journal:  Arthritis Rheum       Date:  1999-01

Review 7.  Mixed connective tissue disease: to be or not to be?

Authors:  J S Smolen; G Steiner
Journal:  Arthritis Rheum       Date:  1998-05

8.  Deletion of TLR3 alters the pulmonary immune environment and mucus production during respiratory syncytial virus infection.

Authors:  Brian D Rudd; Jetse J Smit; Richard A Flavell; Lena Alexopoulou; Matthew A Schaller; Achim Gruber; Aaron A Berlin; Nicholas W Lukacs
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

9.  A murine model of mixed connective tissue disease induced with U1 small nuclear RNP autoantigen.

Authors:  Eric L Greidinger; YunJuan Zang; Kimberly Jaimes; Scott Hogenmiller; Mehdi Nassiri; Pablo Bejarano; Glen N Barber; Robert W Hoffman
Journal:  Arthritis Rheum       Date:  2006-02

10.  Cutting Edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells.

Authors:  Ronan Le Goffic; Julien Pothlichet; Damien Vitour; Takashi Fujita; Eliane Meurs; Michel Chignard; Mustapha Si-Tahar
Journal:  J Immunol       Date:  2007-03-15       Impact factor: 5.422

View more
  8 in total

1.  Conservation of pathogenic TCR homology across class II restrictions in anti-ribonucleoprotein autoimmunity: extended efficacy of T cell vaccine therapy.

Authors:  YunJuan Zang; Laisel Martinez; Irina Fernandez; Judith Pignac-Kobinger; Eric L Greidinger
Journal:  J Immunol       Date:  2014-03-26       Impact factor: 5.422

2.  Diagnosis and risk stratification in patients with anti-RNP autoimmunity.

Authors:  M F Carpintero; L Martinez; I Fernandez; A C Garza Romero; C Mejia; Y J Zang; R W Hoffman; E L Greidinger
Journal:  Lupus       Date:  2015-03-02       Impact factor: 2.911

3.  An Autoimmune Basis for Raynaud's Phenomenon: Murine Model and Human Disease.

Authors:  D P Ascherman; Y Zang; I Fernandez; E S Clark; W N Khan; L Martinez; E L Greidinger
Journal:  Arthritis Rheumatol       Date:  2018-07-25       Impact factor: 10.995

Review 4.  The U1-snRNP complex: structural properties relating to autoimmune pathogenesis in rheumatic diseases.

Authors:  Nicole H Kattah; Michael G Kattah; Paul J Utz
Journal:  Immunol Rev       Date:  2010-01       Impact factor: 12.988

5.  T cell vaccination therapy in an induced model of anti-RNP autoimmune glomerulonephritis.

Authors:  Sapna Trivedi; YunJuan Zang; Schartess Culpepper; Erica Rosenbaum; Irina Fernandez; Laisel Martinez; Robert W Hoffman; Eric L Greidinger
Journal:  Clin Immunol       Date:  2010-08-24       Impact factor: 3.969

6.  Endosomal Toll-like receptors in autoimmunity: mechanisms for clinical diversity.

Authors:  Sapna Trivedi; Eric L Greidinger
Journal:  Therapy       Date:  2009-05-01

Review 7.  The mechanisms and applications of T cell vaccination for autoimmune diseases: a comprehensive review.

Authors:  Xin Huang; Haijing Wu; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

8.  Application of principal component analysis and logistic regression model in lupus nephritis patients with clinical hypothyroidism.

Authors:  Ting Huang; Jiarong Li; Weiru Zhang
Journal:  BMC Med Res Methodol       Date:  2020-05-01       Impact factor: 4.615

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.